Licensing Opportunities

TITLE: A Grain Protein for Novel Dietary Supplement to Inhibit Inflammation in an Aging Brain.

RATIONALE:

  • The proportion of aging population is increasing

  • Ailments of an aging brain including Alzheimer’s disease (AD), frontotemporal dementia (FTD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), etc., have neuroinflammatory background but effective treatments remain elusive

  • To prevent, slow down or inhibit the course of common ailments of aging brain, an effective agent will need to be administered continuously and optimally become a part of one’s diet

PROPOSED SOLUTION:

  • A grain protein administered orally, anti-inflammatory effect crosses the blood brain barrier

  • This effect tested and determined in extensive preclinical studies

  • USPTO patent application H8317407US1

  • International patent application PCT/CA2025/051062

  • GRAS designation

  • Very commonly consumed worldwide

DEAL:

  • We seek a leading international food or nutraceutical company willing to form an exclusive partnership with VPC NeuroTherapeutics Inc. to:

    • Develop and obtain regulatory approvals for a novel dietary food supplement and/or nutraceutical for improvement of aging brain for worldwide markets.

    • Provide an upfront licensing fee and royalties from worldwide sales. TBD.

Please, reply by e-mail:  jmkwiecien@vpcneurotherapeutics.com

Look for us at:

6th Global Summit on

Food Science, Nutrition and Technology

Rome, Italy May 25-26, 2026

Oral Presentation

A Grain Protein with Anti-Neuroinflammatory Activity for Better Function in Aging Brain.

Jacek M. Kwiecien, DVM, MSc, PhD. VPC NeuroTherapeutics Inc., Canada.